Cancer immunotherapy: Overview of immune checkpoint inhibitors

Keyphrases

• Cancer Immunotherapy 100%
• Immune Checkpoint Inhibitors 100%
• T Cell Activation 50%
• Signaling Pathway 50%
• Monoclonal Antibody 50%
• Malignancy 50%
• Cancer Treatment 50%
• Immune System 50%
• Anti-tumor Response 50%
• Cancer Development 50%
• Tumor Antigen 50%
• Tumor Relapse 50%
• Immune Checkpoint 50%
• Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) 50%
• Programmed Cell death-1/programmed Cell Death-ligand 1 50%

Medicine and Dentistry

• Immune Checkpoint Inhibitor 100%
• Cancer Immunotherapy 100%
• Cancer Therapy 50%
• Neoplasm 50%
• T Cell Activation 50%
• Cancer 50%
• Signal Transduction 50%
• Monoclonal Antibody 50%
• Programmed Death 1 Ligand 1 50%
• Immune System 50%
• Tumor Antigen 50%
• CTLA-4 50%
• Programmed Cell Death 50%

Immunology and Microbiology

• Cancer Immunotherapy 100%
• Immune Checkpoint Inhibitor 100%
• T Cell Activation 50%
• Monoclonal Antibody 50%
• Signal Transduction 50%
• Tumor Antigen 50%
• Programmed Cell Death 1 50%
• CTLA-4 50%
• Programmed Death 1 Ligand 1 50%
• Immune System 50%